Rating Change
Needham analysts reiterated a Buy rating on Veracyte, Inc. (NASDAQ:VCYT) on July 31, 2026.
reiterateNASDAQ:VCYT
Needham Reiterates Buy Rating on Veracyte, Inc. (VCYT)
Rating Change Needham analysts reiterated a Buy rating on Veracyte, Inc. (NASDAQ:VCYT) on July 31, 2026. Market Context Veracyte, Inc.
Market Context
Veracyte, Inc. operates in the Healthcare sector. The stock currently trades at $59.78 with a market capitalization of $3.3B.
Analyst coverage from Needham provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Veracyte, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Veracyte, Inc.
Among the 10 most recent ratings: 7 Buy, 2 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 31, 2026 | Needham | Buy | N/A |
| Jul 30, 2026 | Needham | Buy | N/A |
| Jul 15, 2026 | Piper Sandler | Overweight | N/A |
| Jul 14, 2026 | Canaccord Genuity | Hold | N/A |
| Jul 09, 2026 | Morgan Stanley | Underweight | N/A |
Related Tools: Analyst Ratings Dashboard | View VCYT Stock Page
Frequently Asked Questions
What does a Buy rating mean for VCYT?
A Buy rating from Needham reflects the analyst's outlook on Veracyte, Inc. (NASDAQ:VCYT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the VCYT forecast page.